Publication: Plasma concentrations of artemether and its major plasma metabolite, dihydroartemisinin, following a 5-day regimen of oral artemether, in patients with uncomplicated falciparum malaria
Issued Date
1998-02-03
Resource Type
ISSN
00034983
Other identifier(s)
2-s2.0-0031973066
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Annals of Tropical Medicine and Parasitology. Vol.92, No.1 (1998), 31-36
Suggested Citation
J. Karbwang, K. Na-Bangchang, A. Thanavibul, P. Molunto Plasma concentrations of artemether and its major plasma metabolite, dihydroartemisinin, following a 5-day regimen of oral artemether, in patients with uncomplicated falciparum malaria. Annals of Tropical Medicine and Parasitology. Vol.92, No.1 (1998), 31-36. doi:10.1080/00034989860148 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/18396
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Plasma concentrations of artemether and its major plasma metabolite, dihydroartemisinin, following a 5-day regimen of oral artemether, in patients with uncomplicated falciparum malaria
Author(s)
Other Contributor(s)
Abstract
Plasma concentrations of artemether and its active plasma metabolite (dihydroartemisinin) were measured in 49 male, Thai patients with acute, uncomplicated, multidrug-resistant, Plasmodium falciparum malaria, following their treatment with oral artemether (300 mg on the first day, then 100 mg daily for another 4 days). Four patients recrudesced (on days 19-22). After the first dose, artemether became undetectable in ≤ 18 h and this drug was also undetectable in samples collected immediately before each dose. Although dihydroartemisinin followed similar trends, three patients had detectable plasma concentrations of this metabolite 24 h after the first dose (i.e. immediately before the second dose). Median (range) values for plasma concentrations of dihydroartemisinin 6 h [354 (150-751)) v. 196 (178-220) ng/ml] and 12 h [158 (25-420) v. 54 (25-115) ng/ml] after the initial dose, estimated antimalarial activities (calculated as dihydroartemisinin equivalents) 6 h [331 (78.2-644.1) v. 23 (183.3-270) nmol/litre] and 12 h [98.3 (10-192.2) v. 56.7 (9.8-59.4) nmol/litre] after the initial dose, and the corresponding 'areas under the curves' (AUC) [3684 (1562-8216) v. 834 (1401-2030) ng.h/ml] were all significantly higher in the patients with sensitive responses than in those who recrudesced.